The largest database of trusted experimental protocols

Ficoll separation

Manufactured by GE Healthcare
Sourced in Sweden, United States

Ficoll separation is a laboratory technique used to isolate and purify specific cell populations from a heterogenous mixture, such as blood or bone marrow. It utilizes a density gradient medium called Ficoll to separate cells based on their density differences. The core function of Ficoll separation is to enable the isolation of mononuclear cells, such as lymphocytes and monocytes, from other blood components in a gentle and efficient manner.

Automatically generated - may contain errors

12 protocols using ficoll separation

1

Isolation and Culture of Human Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human umbilical vein endothelial cells (HUVECs; Lonza, Walkersville, MD; C2517A) were cultured using EGM-2 MV media (Lonza; CC-3202). KG-1 human leukemia cells (ATCC, Manassas, VA; CCL-246) were grown in IMDM (Hyclone, Fisher Scientific, Hanover Park, IL; SH30228.01) plus 20% FBS.
Bone marrow endothelial cells (BMECs) were freshly isolated from healthy human bone marrow (Lonza). Briefly, mononuclear cells were isolated from fresh bone marrow samples using Ficoll separation (GE Healthcare, Chicago, IL; GE17-1440-02) and plated in collagen-coated plates. Adherent cells were collected and cultured using EGM-2 MV media supplemented with 10% FBS to generate the BMECs.
+ Open protocol
+ Expand
2

Isolation and Cryopreservation of Normal and AML Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Normal donor human blood cells were obtained fresh from AllCells (Alameda, CA) and FACS-enriched. Human AML samples were obtained from patients at the Stanford Medical Center with informed consent, according to Institutional Review Board (IRB)-approved protocols (Stanford IRB no 18329 and 6453). Mononuclear cells were isolated from each AML sample via Ficoll separation (GE Healthcare Life Sciences, Pittsburg, PA) and cryopreserved in liquid nitrogen in 90% FBS + 10% DMSO. All experiments presented here were conducted on freshly thawed cells. Criteria for inclusion of AML samples in this study were pre-established. Samples were included based on blast percentage at sample collection. For normal donors, no exclusion criteria were used. All AML samples were thawed in IMDM + 10% FBS + 200 U/ml DNase (Worthington Biochemical, Lakewood, NJ)
+ Open protocol
+ Expand
3

Isolation and Culture of Various Cell Types

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chinese hamster ovary cells (CHO), human embryonic kidney cells (HEK 293), human umbilical vein endothelial cells (HUVEC) and human epithelial colorectal adenocarcinoma cells (CACO-2) human breast cancer epithelial cells (MCF-7), in addition to primary human cells were purchased from ATCC. Peripheral blood mononuclear cells (PBMCs) were isolated from whole blood samples obtained from healthy volunteers using Ficoll separation (GE Healthcare) as described by the manufacturer. Healthy volunteer blood samples were procured with signed informed consent and IRB approval by Western IRB. Patient blood samples were collected with signed informed consent and an IRB with Inova Fairfax Hospital.
+ Open protocol
+ Expand
4

Isolating PBMCs and Spleen Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral Blood Mononuclear Cells (PBMCs) were isolated from heparinized blood by use of standard Ficoll separation (GE Healthcare, Uppsala, Sweden) and stored at −140°C until use. Donor spleen cells were obtained by mechanical dissociation of spleen from the organ donor. After filtration of the cell suspension, the cells were isolated by Ficoll separation.
+ Open protocol
+ Expand
5

Isolation of Myeloid and Lymphoid Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wounds were digested as described above. Single cell suspensions were incubated with fluorescein isothiocyanate–labeled anti-CD3, anti-CD19, and anti-Ly6G (BioLegend) followed by anti–fluorescein isothiocyanate microbeads (Miltenyi Biotec). Flow-through was then incubated with anti-CD11b microbeads (Miltenyi Biotec) to isolate the non-neutrophil, non-lymphocyte, CD11b+ cells. Cells were saved in Trizol (Invitrogen) for quantitative RT-PCR analyses. For human monocyte isolation, peripheral blood was collected and subjected to RBC lysis and Ficoll separation (GE healthcare). Cell suspensions were then treated with anti-human CD14 microbeads. Magnetic separation yielded 95% purity by flow cytometry.
+ Open protocol
+ Expand
6

Synovial Fluid and PBMC Analysis in ACPA+ and ACPA- RA

Check if the same lab product or an alternative is used in the 5 most similar protocols
This study was approved by the research ethics committee of Karolinska University Hospital, Sweden and all patients signed informed consent according to the Declaration of Helsinki. All patients had established disease, based on the 1987 criteria from the American College of Rheumatology. Synovial fluid from ACPA− (n = 13) and ACPA+ (n = 16) RA patients were collected at several visits at the Rheumatology Clinic of Karolinska University Hospital, Stockholm (Supplementary Data 1). In n = 12 ACPA− and n = 10 ACPA+ RA patients, paired PBMCs were also available. PBMC and SFMC were isolated by Ficoll separation (GE Healthcare) and cryopreserved in fetal bovine serum (FBS) with 10% DMSO in liquid nitrogen.
+ Open protocol
+ Expand
7

Longitudinal Profiling of Rheumatoid Arthritis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood and synovial tissue samples were collected before treatment (baseline (FU0)), at week 4 (follow-up 1 (FU1)) and at week 16 (follow-up 2 (FU2)) after rituximab treatment, as described before.12 14 (link) For some patients the week 16 post-treatment peripheral blood sample was not available and peripheral blood samples collected at week 24 were analysed instead. Peripheral blood mononuclear cells (PBMCs) were isolated from total blood using Ficoll separation (GE Healthcare, ref 17-1440-02) and cryopreserved in liquid nitrogen until RNA isolation. Synovial tissue biopsies were collected by needle arthroscopy as previously described15 (link) from an inflamed knee as judged by the treating physician and cryopreserved in liquid nitrogen until RNA isolation.
+ Open protocol
+ Expand
8

Isolation and Purification of Wound Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
MACs sorting of wound cell isolates was performed (Mirza et al., 2013 (link)). Briefly, wound cell isolates were incubated with fluorescein isothiocyanate (FITC)-labeled anti-mouse anti-CD3 (RRID:AB_312660), anti-NK1.1 (RRID:AB_448547), anti-CD19 (RRID:AB_2629813), and anti-Ly6G (Biolegend, RRID:AB_470400) monoclonal antibodies conjugated to FITC. Wound isolates were then washed and incubated with anti-FITC microbeads (Miltenyi Biotec, RRID:AB_244371, cat No. 130-049-601) and passed through a MACs column (Miltenyi Biotec). The resultant eluent was then incubated with anti-mouse anti-CD11b microbeads, (Miltenyi Bioter, cat No. 130-049-601). The remaining cell population was analyzed by flow cytometry and found to be 97% macrophages consistent with previous literature (Gallagher et al., 2015 (link); Mirza et al., 2013 (link)). For human monocyte isolation, peripheral blood was collected and subjected to RBC lysis and Ficoll separation (GE healthcare). Cell suspensions were then treated with anti-human CD14 microbeads. Magnetic separation yielded 95% purity by flow cytometry.
+ Open protocol
+ Expand
9

Feline and Murine IFNγ ELISPOT Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse splenocytes or feline PBMCs isolated by ficoll separation (GE Healthcare) were maintained in Roswell Park Memorial Institute medium supplemented with fetal bovine sera, penicillin/streptomycin. Feline PBMCs were supplemented with 0.5 ng/mL feline IL2 (R&D Systems). Cells were plated at 2x105/well in round bottom 96-well plates and cultured with 10 μg/mL feHER2-Fc (3T3 supernatant-equivalent as described above), huHER2-Fc, human IgG control (Jackson Immunolabs) or control 3T3-conditioned medium for 48 (mouse) or 72 (feline) hours. Total well contents were then transferred to mouse or feline (R&D Systems) IFNγ ELISPOT plates and incubated for an additional 48 hours prior to detection and enumeration as previously described (44 (link)) or per manufacturer protocol. Visualized cytokine spots were enumerated using the ImmunoSpot analyzer (CTL, Shaker Heights, OH) and expressed as the number of cytokine-producing cells per 106 splenocytes or PBMCs.
+ Open protocol
+ Expand
10

Peripheral Blood Mononuclear Cells in Tuberculosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sixty patients with TB and 60 healthy volunteers were recruited in this study at the Third People's Hospital of Kunming City during 2015‐2017. The diagnostic criteria for TB were TB symptoms by a chest X‐ray alone with positivity for M tb culture. The TB patients had no immune deficiency disease, hepatitis B, diabetes or other pulmonary‐related complications. Healthy controls were recruited from volunteers who had a routine physical examination at Third People's Hospital of Kunming City. The peripheral blood were collected into ETDA‐treated tubes from patients when admitted to the hospital for the first time. The PBMCs were isolated from the peripheral blood via density gradient centrifugation by Ficoll separation (GE Healthcare, Chicago, USA). After washing with PBS, the PBMCs were then subjected to further analysis. The study protocol was approved by the Institutional Ethics Committee Board of the Third People's Hospital of Kunming City, and the informed consent was obtained from each volunteer.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!